During the past decade, Szpital Sw. Wojciecha conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Szpital Sw. Wojciecha" are "Huntington Disease" (3 trials), "Huntington's Disease" (2 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Szpital Sw. Wojciecha" in a lesser frequency.

Most popular intervention types in "Szpital Sw. Wojciecha" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "WVE-120101" (2 trials), "WVE-120102" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Sw. Wojciecha" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Szpital Sw. Wojciecha". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Szpital Sw. Wojciecha, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Sw. Wojciecha, 5 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".